Skip to main content

Advertisement

SpringerLink
Log in

Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

There are limited and controversial data regarding the impact of 4G/5G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene in the pathogenesis of premature myocardial infarction (MI). We explored whether 4G/5G polymorphism of the PAI-1 gene is associated with the development of MI ≤ 35 years of age. We recruited 201 consecutive patients who had survived their first acute MI ≤ 35 years of age (mean age = 32.2 ± 3.4 years). The control group consisted of 140 healthy individuals matched with cases for age and sex, without a family history of premature coronary heart disease. 4G/5G polymorphism of PAI-1 was tested with polymerase chain reaction and reverse hybridization. 4G allele carriers (4G/4G and 4G/5G genotypes) of PAI-1 were less frequent in patients than in controls (69.6 vs. 83.6%, P = 0.007). 4G carriership of the polymorphism of PAI-1 was associated with lower risk for acute MI (odds ratio 0.45, 95% confidence interval 0.23–0.88, P = 0.02) after adjusting for major cardiovascular risk factors. Patients possessing the 4G allele had higher PAI-1 plasma levels (32.2 ± 25 vs. 22.2 ± 11.3 ng/ml, P = 0.006) but lower lipoprotein(a) levels (10.1 [2.1–29.9] vs. 15.3 [8.2–57.1] mg/dl, P = 0.03) compared to 5G/5G homozygotes. Our data indicate that the 4G allele of the PAI-1 4G/5G polymorphism is less frequent among survivors of MI at very young age compared with matched controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Voetsch B, Loscalzo J (2004) Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24:216–229

    Article  CAS  PubMed  Google Scholar 

  2. Zimmerman FH, Cameron A, Fisher LD, Ng G (1995) Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26:654–661

    Article  CAS  PubMed  Google Scholar 

  3. Glueck CJ, Munjal J, Aregawi D, Agloria M, Winiarska M, Khalil Q, Wang P (2007) Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease ≤ age 45 years. Transl Res 150:93–100

    Article  CAS  PubMed  Google Scholar 

  4. Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M (1999) Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94:46–51

    CAS  PubMed  Google Scholar 

  5. Rallidis LS, Belesi CI, Manioudaki HS, Chatziioakimidis VK, Fakitsa VC, Sinos LE, Laoutaris NP, Apostolou TS (2003) Myocardial infarction under the age of 36: prevalence of thrombophilic disorders. Thromb Haemost 90:272–278

    CAS  PubMed  Google Scholar 

  6. Hamsten A, de Faire U, Walldius G, Dahlén G, Szamosi A, Landou C, Blombäck M, Wiman B (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3–9

    Article  CAS  PubMed  Google Scholar 

  7. Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792–1801

    Article  CAS  PubMed  Google Scholar 

  8. Vaughan DE, PAI-1, atherothrombosis (2005) J Thromb Haemost 3:1879–1883

    Article  CAS  PubMed  Google Scholar 

  9. van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ (1988) Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 72:1467–1473

    PubMed  Google Scholar 

  10. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S (2004) Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 104:3943–3948

    Article  CAS  PubMed  Google Scholar 

  11. Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D (1988) Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemost 60:491–494

    CAS  PubMed  Google Scholar 

  12. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739–10745

    CAS  PubMed  Google Scholar 

  13. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP et al. (1995) The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I’nfarctus du Myocarde. Thromb Haemost 74:837–841

    Google Scholar 

  14. Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, Altay C, Gurgey A, Nazli N (2008) Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis 26:211–217

    Article  CAS  PubMed  Google Scholar 

  15. Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y (2001) Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J (Engl) 114:266–269

    CAS  Google Scholar 

  16. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ (1997) Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol 17:33–37

    CAS  PubMed  Google Scholar 

  17. Mikkelsson J, Perola M, Wartiovaara U, Peltonen L, Palotie A, Penttilä A, Karhunen PJ (2000) Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly. Thromb Haemost 84:78–82

    CAS  PubMed  Google Scholar 

  18. Zhan M, Zhou Y, Han Z (2003) Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. Chin Med J (Engl) 116:1707–1710

    CAS  Google Scholar 

  19. Anderson JL, Muhlestein JB, Habashi J, Carlquist JF, Bair TL, Elmer SP, Davis BP (1999) Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol 34:1778–1783

    Article  CAS  PubMed  Google Scholar 

  20. Ding J, Nicklas BJ, Fallin MD, de Rekeneire N, Kritchevsky SB, Pahor M, Rodondi N, Li R, Zmuda JM, Harris TB (2006) Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am Heart J 152:1109–1115

    Article  CAS  PubMed  Google Scholar 

  21. Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR (1999) The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82:115–120

    CAS  PubMed  Google Scholar 

  22. Crainich P, Jenny NS, Tang Z, Arnold AM, Kuller LH, Manolio T, Sharrett AR, Tracy RP (2003) Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly. J Thromb Haemost 1:1799–1804

    Article  CAS  PubMed  Google Scholar 

  23. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP (1997) Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95:59–62

    CAS  PubMed  Google Scholar 

  24. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Büller HR, Peters RJ (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104:3063–3068

    Article  CAS  PubMed  Google Scholar 

  25. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367:651–658

    Article  CAS  PubMed  Google Scholar 

  26. Junker R, Heinrich J, Schulte H, Tataru M, Köhler E, Schönfeld R, Nowak-Göttl U, Assmann G (1998) Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. Blood Coagul Fibrinolysis 9:597–602

    Article  CAS  PubMed  Google Scholar 

  27. Thrombosis Atherosclerosis Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117–1122

    Article  Google Scholar 

  28. Eriksson P, Kallin B, van ‘t Hooft FM, Båvenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851–1855

    Article  CAS  PubMed  Google Scholar 

  29. Hindorff LA, Schwartz SM, Siscovick DS, Psaty BM, Longstreth WT Jr, Reiner AP (2002) The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women. J Cardiovasc Risk 9:131–137

    Article  PubMed  Google Scholar 

  30. Isordia-Salas I, Leaños-Miranda A, Sainz IM, Reyes-Maldonado E, Borrayo-Sánchez G (2009) Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients. Rev Esp Cardiol 62:365–372

    Article  PubMed  Google Scholar 

  31. Nomenclature and criteria for diagnosis of ischemic heart disease (1979) Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59:607–609

    Google Scholar 

  32. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

    CAS  PubMed  Google Scholar 

  33. Schneider DJ, Hayes M, Wadsworth M, Taatjes H, Rincón M, Taatjes DJ, Sobel BE (2004) Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). J Histochem Cytochem 52:1091–1099

    Article  CAS  PubMed  Google Scholar 

  34. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S, Lawrence DA, Okada SS (2001) Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1. Circulation 103:597–603

    CAS  PubMed  Google Scholar 

  35. Incalcaterra E, Hoffmann E, Averna MR, Caimi G (2004) Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol 52:287–312

    CAS  PubMed  Google Scholar 

  36. Rallidis LS, Gialeraki A, Komporozos C, Vavoulis P, Pavlakis G, Travlou A, Lekakis I, Kremastinos DT (2008) Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction. Atherosclerosis 200:115–120

    Article  CAS  PubMed  Google Scholar 

  37. Rallidis LS, Politou M, Komporozos C, Panagiotakos DB, Belessi CI, Travlou A, Lekakis J, Kremastinos DT (2008) Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost 99:1085–1089

    CAS  PubMed  Google Scholar 

  38. Jovin IS, Müller-Berghaus G (2004) Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis. Atherosclerosis 174:225–233

    CAS  PubMed  Google Scholar 

  39. Loscalzo J, Weinfeld M, Fless GM, Scanu AM (1990) Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 10:240–245

    CAS  PubMed  Google Scholar 

  40. Undas A, Stepien E, Tracz W, Szczeklik A (2006) Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost 4:973–975

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Cardiology, Attikon Hospital, School of Medicine, University of Athens, Athens, Greece

    Loukianos S. Rallidis, Nikolaos Dagres, John Lekakis & Dimitrios T. Kremastinos

  2. Laboratory of Haematology and Blood Transfusion Unit, Attikon Hospital, School of Medicine, University of Athens, Athens, Greece

    Argyri Gialeraki, Efrosyni Merkouri & Anthi Travlou

  3. Biochemistry Laboratory, General Hospital of Nikea, Piraeus, Greece

    George Liakos

  4. Department of Interventional Cardiology, 1st IKA Hospital, Athens, Greece

    Dimitrios Sionis

  5. 74 Thermopylon Street, 16451, Argiroupolis, Greece

    Loukianos S. Rallidis

Authors
  1. Loukianos S. Rallidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Argyri Gialeraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Efrosyni Merkouri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George Liakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nikolaos Dagres
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dimitrios Sionis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anthi Travlou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John Lekakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dimitrios T. Kremastinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Loukianos S. Rallidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rallidis, L.S., Gialeraki, A., Merkouri, E. et al. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction. J Thromb Thrombolysis 29, 497–502 (2010). https://doi.org/10.1007/s11239-009-0398-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-009-0398-z

Keywords

Search

Navigation